#Gilead Sciences

The results of GLAAD’s first State of HIV Stigma Study coincide with news of a $9 million Gilead grant to fight HIV in the South.

Plus: The Elizabeth Taylor AIDS Foundation and Gilead Sciences join the collective for a virtual town hall June 25.

Safeway and other Albertsons pharmacies will also participate, allowing uninsured clients to fill PrEP prescriptions at no cost.

Results from randomized clinical trials of the antiviral drug continue to show mixed results.

Hint: Gilead Sciences donated the meds for Trump’s HIV prevention program, so that cost isn’t the issue.

Scripts and testing don’t require visits to the doc thanks to this partnership between Texas Health Action and the telemedicine portals.

Envelopes were sent to people in the pharma giant’s patient assistance program for PrEP.

Gilead Sciences provides the funds through its TRANScend initiative; Destination Tomorrow in the Bronx distributes them.

Bonus: Your donations to the Broadway Cares effort Emergency Grants for Pandemic Relief will be matched by Gilead Sciences.

Groups already receiving grants from the pharma giant can apply for new funds during the coronavirus crisis.

This week’s NMAC Hangout is with leaders committed to support the HIV infrastructure during and eventually after the COVID-19 outbreak.

As a result, researchers in Spain are testing whether HIV med Truvada, often used as PrEP, can also prevent COVID-19.

Jevon Martin, CEO of Princess Janae Place, addresses the challenges facing trans people—including COVID-19.

The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.

Researchers are looking for ways to reduce the doses needed for on-demand PrEP and the 30-day duration recommended for PEP.

What has happened since health experts identified an HIV cluster in Huntington, West Virginia, in 2018?